title: Safety of calcium antagonists: more ACTION.
authors.affiliation: St. Lukes-Roosevelt Hospital Corporation, New York City, New York, USA. fmesserli@aol.com
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
authors.forename: Jan A
authors.initials: JA
authors.lastname: Staessen
mesh_terms: D000789:Angina, Unstable / Q000150:complications / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D015331:Cohort Studies; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced*; D009543:Nifedipine / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D002121:Calcium Channel Blockers; D009543:Nifedipine